Cui Xizhong, Besch Virginia, Khaibullina Alfia, Hergen Adrienne, Quezado Martha, Eichacker Peter, Quezado Zenaide M N
Critical Care Medicine Department, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Intensive Care Med. 2007 Nov;33(11):1993-2003. doi: 10.1007/s00134-007-0814-9. Epub 2007 Aug 8.
To investigate the role of neuronal nitric oxide synthase (NOS1) in murine polymicrobial peritonitis and sepsis.
Randomized experimental trial.
Animal research facility.
B6129S NOS1+/+ and B6;129S4 NOS-/- mice.
NOS1+/+ and NOS1-/- animals underwent cecal ligation and puncture (CLP) or sham surgery and received the NOS1 inhibitor 7-nitroindazole (7-NI) or vehicle.
After CLP, genetic deficiency and pharmacologic inhibition of NOS1 significantly increased risk of mortality [8.69 (3.27, 23.1), p<0.0001 and 1.71 (1.00, 2.92) p=0.05, hazard ratio of death (95% confidence interval) for NOS1-/- and 7-NI-treated NOS1+/+ respectively] compared with NOS1+/+ animals. In 7-NI-treated NOS1+/+ animals, there were increases (6 h) and then decreases (24 h), whereas in NOS-/- animals persistent increases in blood bacteria counts (p=0.04 for differing effects of 7-NI and NOS1-/-) were seen compared with NOS1(+/+) animals. After CLP, NOS1(-/-) had upregulation of inducible NOS and proinflammatory cytokines and greater increases in serum tumor necrosis factor-alpha and interleukin-6 levels compared with NOS1+/+ mice (all p<0.05). Following CLP, there were similar significant decreases in circulating leukocytes and lung lavage cells (p<or=0.0008) and significant increases in peritoneal lavage cells (p=0.0045) in all groups. Over 6 h and 24 h following CLP, compared with NOS1+/+, NOS-/- mice had significantly higher peritoneal cell concentrations {respectively 0.40+/-0.09 vs 0.79+/-0.15 [log(x10(4)cells/ml)] averaged over both times p=0.038}.
Deficiency and inhibition of NOS1 increases mortality, possibly by increasing proinflammatory cytokine response and impairing bacterial clearance after CLP. These data suggest that NOS1 is important for survival, bacterial clearance, and regulation of cytokine response during infection and sepsis.
研究神经元型一氧化氮合酶(NOS1)在小鼠多菌性腹膜炎和脓毒症中的作用。
随机实验性试验。
动物研究设施。
B6129S NOS1+/+和B6;129S4 NOS-/-小鼠。
NOS1+/+和NOS1-/-动物接受盲肠结扎和穿刺(CLP)或假手术,并接受NOS1抑制剂7-硝基吲唑(7-NI)或赋形剂。
CLP后,与NOS1+/+动物相比,NOS1基因缺陷和药物抑制显著增加死亡风险[分别为8.69(3.27,23.1),p<0.0001和1.71(1.00,2.92),p=0.05,NOS1-/-和7-NI处理的NOS1+/+的死亡风险比(95%置信区间)]。在7-NI处理的NOS1+/+动物中,血细菌计数先升高(6小时)然后降低(24小时),而在NOS-/-动物中,与NOS1(+/+)动物相比,血细菌计数持续升高(7-NI和NOS1-/-的不同效应,p=0.04)。CLP后,与NOS1+/+小鼠相比,NOS1(-/-)诱导型NOS和促炎细胞因子上调,血清肿瘤坏死因子-α和白细胞介素-6水平升高幅度更大(均p<0.05)。CLP后,所有组循环白细胞和肺灌洗细胞均显著减少(p≤0.0008),腹腔灌洗细胞显著增加(p=0.0045)。CLP后6小时和24小时内,与NOS1+/+相比,NOS-/-小鼠腹腔细胞浓度显著更高{两次平均分别为0.40±0.09对0.79±0.15[log(x10(4)细胞/ml)],p=0.038}。
NOS1缺陷和抑制增加死亡率,可能是通过增加促炎细胞因子反应和损害CLP后的细菌清除。这些数据表明,NOS1在感染和脓毒症期间对生存、细菌清除和细胞因子反应调节很重要。